MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 247 filers reported holding MIRATI THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,133 | -100.0% | 25 | -100.0% | 0.00% | -100.0% |
| Q3 2022 | $18,177,000 | +2.1% | 260,270 | -1.8% | 0.05% | +10.4% |
| Q2 2022 | $17,800,000 | -16.5% | 265,156 | +2.3% | 0.05% | 0.0% |
| Q1 2022 | $21,312,000 | -43.9% | 259,207 | +0.1% | 0.05% | -32.4% |
| Q4 2021 | $37,971,000 | +38.1% | 258,848 | +66.6% | 0.07% | +36.5% |
| Q3 2021 | $27,492,000 | +10.0% | 155,400 | +0.5% | 0.05% | +10.6% |
| Q2 2021 | $24,989,000 | -7.0% | 154,700 | -1.4% | 0.05% | -9.6% |
| Q1 2021 | $26,866,000 | -49.4% | 156,839 | -35.2% | 0.05% | -52.3% |
| Q4 2020 | $53,142,000 | +51.2% | 241,952 | +14.3% | 0.11% | +32.9% |
| Q3 2020 | $35,150,000 | +73.0% | 211,685 | +19.0% | 0.08% | +64.0% |
| Q2 2020 | $20,317,000 | +1650.0% | 177,950 | +1078.4% | 0.05% | +1566.7% |
| Q1 2020 | $1,161,000 | +171.3% | 15,101 | +355.0% | 0.00% | +200.0% |
| Q4 2019 | $428,000 | -85.8% | 3,319 | -91.4% | 0.00% | -85.7% |
| Q3 2019 | $3,005,000 | -70.8% | 38,564 | -61.5% | 0.01% | -72.0% |
| Q2 2019 | $10,305,000 | -6.0% | 100,044 | -33.1% | 0.02% | -7.4% |
| Q1 2019 | $10,960,000 | +230.1% | 149,527 | +91.0% | 0.03% | +200.0% |
| Q4 2018 | $3,320,000 | -41.4% | 78,272 | -34.9% | 0.01% | -30.8% |
| Q3 2018 | $5,667,000 | +237.1% | 120,317 | +252.8% | 0.01% | +160.0% |
| Q2 2018 | $1,681,000 | +1193.1% | 34,099 | +707.3% | 0.01% | – |
| Q1 2018 | $130,000 | -32.6% | 4,224 | -60.0% | 0.00% | -100.0% |
| Q4 2017 | $193,000 | -15.7% | 10,568 | -46.0% | 0.00% | 0.0% |
| Q3 2017 | $229,000 | +209.5% | 19,569 | -3.3% | 0.00% | – |
| Q2 2017 | $74,000 | +1750.0% | 20,247 | +2363.1% | 0.00% | – |
| Q1 2017 | $4,000 | -33.3% | 822 | -39.0% | 0.00% | – |
| Q4 2016 | $6,000 | -33.3% | 1,348 | +326.6% | 0.00% | – |
| Q1 2015 | $9,000 | – | 316 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |